# A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

> **NCT00483171** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 699 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** CP-945,598
- **BEHAVIORAL:** Non-pharmacological weight loss program (NPP)
- **BEHAVIORAL:** Low Calorie Diet

## Key facts

- **NCT ID:** NCT00483171
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 699 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2012-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00483171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00483171, "A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00483171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*